nervous system
• increased total ganglioside content in the cerebellum and cerebrum-brainstem
• N-butyldeoxygalacto-nojirimycin (NB-DGJ), an imino sugar that inhibits ganglioside biosynthesis, significantly reduced total ganglioside and GM1 content when administered from P9-P15
|
• increased total ganglioside content in the cerebellum and cerebrum-brainstem
• N-butyldeoxygalacto-nojirimycin (NB-DGJ), an imino sugar that inhibits ganglioside biosynthesis, significantly reduced total ganglioside and GM1 content when administered from P9-P15
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
GM1 gangliosidosis | DOID:3322 | J:98543 |